Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The Mio-Training: Efficacy of a metacognitive intervention for children and adolescents – a randomized controlled trial
ABSTRACT
Background:
Disease during childhood and adolescence such as cancer, or ADHD can have an impact on brain development and places children and adolescents at increased risk for cognitive long-term problems. Most cognitive trainings currently available have limited efficacy and lack a transfer to non-trained tasks and everyday functioning. We developed a novel intervention (Mio-Training) aiming to increase metacognitive abilities at the intersection between exercise psychology and cognitive science to strengthen the cognitive development of paediatric patients with atypical brain development in the long-term.
Objective:
The study assesses the efficacy of the Mio-Training on the primary (metacognitive abilities) and secondary outcomes (executive functions, processing speed, memory), before, immediately after the training and at 3-months follow-up in patients with atypical development and healthy controls.
Methods:
We will evaluate the efficacy of a newly developed cognitive training (Mio-Training) on metacognitive abilities and cognitive performance in a randomized controlled clinical trial. We expect a long-term increase in metacognitive abilities relating to an increase in subjective and objective cognitive performance. Intervention: The Mio-Training stimulates metacognition through 38 digital games, which playfully teach mnemonic strategies (i.e. rehearsal, chaining, associations), present intensive verbal and visual working memory training and motor coordination tasks. The training group will train for 5 weeks, 3 times per week for 20 minutes. The waiting control group will receive the training after termination of the study procedure. Participants: The efficacy of the Mio-Training will be investigated in three subgroups (patients with cancer, ADHD and healthy controls, each group n = 40, all aged 8-16 years) using pre- and post-intervention assessments. All participants will be randomly assigned to the Mio-Training or the waiting control group, stratified by age and sex.
Results:
This study protocol describes the study design of the randomized controlled trial evaluating the efficacy of the Mio-Training. Data collection started in August 2025 and will continue until August 2027. First results are expected to be submitted for publication in spring 2027.
Conclusions:
To strengthen cognitive development in young patients with atypical development, it is necessary to address the current lack of effective treatment options. The combination of cognitive and motor training with metacognitive abilities may support patient’s cognitive maturation trajectory and will enable a transfer of the training effect to everyday and school situations. Clinical Trial: Clinicaltrials.gov (Patients with cancer and healthy controls: NCT06464237, date of registration: 12.06.2024, ADHD: NCT07162831, date of registration: 01.09.2025)
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.